Safety of Semaglutide. | Front Endocrinol (Lausanne);12: 645563, 2021. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Safety of Semaglutide.

Smits, Mark M; Van Raalte, Daniël H.

Affiliation

Smits MM; Diabetes Center, Department of Internal Medicine, Amsterdam University Medical Center, Amsterdam, Netherlands.
Van Raalte DH; Diabetes Center, Department of Internal Medicine, Amsterdam University Medical Center, Amsterdam, Netherlands.

Front Endocrinol (Lausanne) ; 12: 645563, 2021.

Article in En | MEDLINE | ID: mdl-34305810

Subject(s)
Key words

glucagon-like peptide-1 receptor agonist (GLP-1RA); oral; safety; semaglutide; subcutaneous; type 2 diabetes

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cholelithiasis / Diabetes Mellitus, Type 2 / Glucagon-Like Peptides Limits: Animals / Humans Language: En Journal: Front Endocrinol (Lausanne) Year: 2021 Document type: Article Affiliation country:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cholelithiasis / Diabetes Mellitus, Type 2 / Glucagon-Like Peptides Limits: Animals / Humans Language: En Journal: Front Endocrinol (Lausanne) Year: 2021 Document type: Article Affiliation country: